Skip to content

Postextubation High-flow Therapy vs Noninvasive Ventilation in Obese or at High-risk Patients

Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation in Obese or High-Risk Patients. A Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04125342
Acronym
HINFOR
Enrollment
326
Registered
2019-10-14
Start date
2020-06-01
Completion date
2021-12-01
Last updated
2022-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extubation Failure

Brief summary

The main aim is to demonstrate whether reintubation rate is lower with preventive conditioned noninvasive ventilation (NIV) rather than with High-flow oxygen therapy (HFOT) in obese intermediate-risk patients and in high-risk patients.

Interventions

DEVICEPreventive Conditioned NIV Therapy after planned extubation

Conditioned NIV during 48 hours following extubation.

DEVICEPreventive HFOT after planned extubation

HFOT set according to patients tolerance during 48 hours following extubation

Sponsors

Hospital Virgen de la Salud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. High-Risk Patients: Patients under mechanical ventilation for more than 24 hours considered at high risk according to the presence of more than 3 of the following risk factors: * \>65 years. * Cardiac failure as the primary indication of mechanical ventilation. * Moderate to severe chronic obstructive pulmonary disease. * APACHE II \>12 points the extubation day. * Body mass index \>30. * Inability to manage respiratory secretions. * Not simple weaning. * More than 1 comorbidity. * More than 7 days under mechanical ventilation. * Hypercapnia during the spontaneous breathing trial. * Airway patency problems. 2. Obese Intermediate Risk Patients: Patients under mechanical ventilation for more than 24 hours with a Body mass index \>30 and considered at intermediate risk according to the presence of less than 3 of the following risk factors: * \>65 years. * Cardiac failure as the primary indication of mechanical ventilation. * Moderate to severe chronic obstructive pulmonary disease. * APACHE II \>12 points the extubation day. * Inability to manage respiratory secretions. * Not simple weaning. * More than 1 comorbidity. * More than 7 days under mechanical ventilation. * Airway patency problems.

Exclusion criteria

* \<18 years. * Thacheotomized patients. * Contraindications for NIV (recent facial or cervical trauma/surgery, active gastro-intestinal bleeding, lack of cooperation). * Unscheduled extubation. * Do not reintubate orders. * No informed consent.

Design outcomes

Primary

MeasureTime frame
Reintubation rate7 days

Secondary

MeasureTime frame
Intensive Care Unit mortality rate3 months
Hospital mortality rate3 months
Intensive Care Unit length of stay3 months
Hospital length of stay6 months
Respiratory infection rate6 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026